TỔNG QUAN VỀ KẾT QUẢ PHẪU THUẬT CẮT THÙY TUYẾN GIÁP TRONG VI UNG THƯ TUYẾN GIÁP THỂ NHÚ

Abstract

Objective: This review evaluates the outcomes after lobectomy (mortality rate, overall survival rate, and recurrence rates) and give the standards of the indication for lobectomy in patients with papillary thyroid microcarcinoma. Methods: We used the PUBMED and EMBASE databases to evaluate the results and indications of lobectomy for papillary thyroid carcinoma. Results: There were 09 studies with 5345 patients in this overview, the average follow-up time was 64.6 - 134.8 months. In these studies, we did not see any deaths related to thyroid carcinoma after lobectomy. Kaplein-Meier disease-free survival was lower in lobectomy group than total thyroidectomy group. The overall recurrence rate after lobectomy is 2.5%, the recurrence site after this surgery is 75.3% in the remaining thyroid lobe, 1.5% at the thyroid bed, and cervical lymph node metastasis is 23.2%. There were no cases of distant metastases during the follow-up period. Conclusion: Lobectomy has similar results as total thyroidectomy in papillary thyroid carcinoma (mortality rate, overall survival, recurrence rate). Therefore, lobectomy may be indicated for papillary thyroid microcarcinoma, provided the standards conditions are satisfied.